Join to View Full Profile
10 Center DrBuilding 10 Room 52448Bethesda, MD 20814
Phone+1 301-761-7094
Fax+1 877-303-1460
Dr. Gaudinski is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- MedStar Health Georgetown University/Georgetown HospitalResidency, Internal Medicine, 2011 - 2014
- Georgetown University School of MedicineClass of 2011
Certifications & Licensure
- MD State Medical License 2012 - 2026
- DC State Medical License 2011 - 2024
- VA State Medical License 2011 - 2016
- American Board of Allergy and Immunology Allergy & Immunology
Clinical Trials
- Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-EBOMAB092-00-AB (MAb114), Administered Intravenously to Healthy Adults Start of enrollment: 2018 May 16
- Phase I, Open-Label, Dose-Escalation Study of a Human Monoclonal Antibody, VRC-HIVMAB091-00-AB (N6LS), Administered Intravenously or Subcutaneously With or Without Recombinant Human Hyaluronidase PH20 (rHuPH20) Start of enrollment: 2018 Jun 21
- Phase I Study to Evaluate a Human Monoclonal Antibody (MAb) 10E8VLS Administered Alone or Concurrently With MAb VRC07-523LS Via Subcutaneous Injection in Healthy Adults Start of enrollment: 2018 Jul 10
Publications & Presentations
PubMed
- Safety and immunogenicity of a modified mRNA-lipid nanoparticle vaccine candidate against COVID-19: Results from a phase 1, dose-escalation study.Brandon J Essink, Craig Shapiro, Marie Grace Dawn Isidro, Paul Bradley, Antoinette Pragalos
Human Vaccines & Immunotherapeutics. 2024-12-31 - 2 citationsPhase 1 trial evaluating safety and pharmacokinetics of HIV-1 broadly neutralizing mAbs 10E8VLS and VRC07-523LS.Seemal F Awan, Amarendra Pegu, Larisa Strom, Cristina A Carter, Cynthia S Hendel
JCI Insight. 2024-04-08 - 9 citationsSafety, tolerability, and immunogenicity of the Ebola Sudan chimpanzee adenovirus vector vaccine (cAd3-EBO S) in healthy Ugandan adults: a phase 1, open-label, dose-es...Betty Mwesigwa, Katherine V Houser, Amelia R Hofstetter, Ana M Ortega-Villa, Prossy Naluyima
The Lancet. Infectious Diseases. 2023-12-01
Press Mentions
- Monoclonal Antibody Prevents Malaria in Small NIH TrialAugust 13th, 2021
- New Mechanism Meditates Link Between Fetal Conditions and Later HealthAugust 10th, 2021
- First Human Trial of Monoclonal Antibody to Prevent Malaria OpensJanuary 29th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: